Applied DNA Sciences (APDN) Tops Q3 EPS by 5c

Applied DNA Sciences (NASDAQ: APDN) reported Q3 EPS of ($0.08), $0.05 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $2.3 million versus the consensus estimate of $1.45 million.

For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.

You May Also Be Interested In

• Fox upgraded to overweight as Roku deal, ad strength lift outlook
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Prosensa Holding N.V. (RNA) Reports Q2 Loss of $1.18